IX Biopharma Advances in Drug Development

TipRanksMar 20 06:17

Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer

Singapore Strait Times Index rose on Tuesday at the close, tracking overnight gains in the global markets after global equities ended mixed overnight. During the day, the benchmark index ranged betwee

MT NewswiresMar 12 04:40

IX Biopharma Introduces New Sublingual Wafer

iX Biopharma (SGX:42C) added a new drug candidate, iXB 401 to its pharma development pipeline, according to a news release on the Singapore Exchange on Monday. The novel semaglutide wafer offers great

MT NewswiresMar 12 00:31

IX Biopharma Targets Diabetes With New Wafer

TipRanksMar 11 04:47

Singapore Stocks Linger in Red; IX Biopharma's Shares Soar 12% Following Unveiling of Novel Drug Delivery System

Singapore Strait Times Index opened marginally higher on Tuesday but slipped back into the negative territory at the close, following overnight losses in global markets. During the day, the benchmark

MT NewswiresMar 5 03:33

IX Biopharma Unveils Novel Drug Delivery System; Shares Surge 12%

iX Biopharma (SGX:42C) unveiled a specialized drug delivery system, the NAD wafers at the Center for Healthy Longevity Conference, according to a Monday filing. Through this non-invasive infusion, the

MT NewswiresMar 4 20:54